0
Journal Cover
Current Issue >
June 2013
Vol 70, No. 6
Subscribe via RSS   Email Alerts
Please Wait... Processing your request... Please Wait.

NEW—The JAMA Network Reader Web App

Get started today at mobile.jamanetwork.com.

Image of the New JAMA Network Reader Web App

Not a subscriber yet?

Subscribe to JAMA Psychiatry for 12 months of high-impact, peer-reviewed original articles and unique features. Subscribe/Learn More

In the Media
Potential of Pretreatment Neural Activity in the Visual Cortex During Emotional Processing to Predict Treatment Response to Scopolamine in Major Depressive Disorder. Furey et al.

Coverage by:
Psychiatric News
MedPage Today
Health Canal.Com

Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals. Wium-Andersen et al.

Coverage by:
Everyday Health
MedPage Today
Medscape

Read more media coverage here.

Recent Tweets from JAMA Psychiatry

Follow us on Twitter

Latest Content Highlights

Follow Us

  • Original Article |  June 19, 2013

    Analysis of PTSD

    Bryant and colleagues test the roles of initial psychiatric reactions, mild traumatic brain injury, and ongoing stressors on delayed-onset posttraumatic stress disorder.

  • Original Article |  June 19, 2013

    Maternal Depressive Symptoms

    To examine whether early child care moderates associations between maternal depressive symptoms and child internalizing problems (emotional problems, separation anxiety symptoms, and social withdrawal symptoms) during the preschool period, Herba et al performed a population-based prospective cohort study within the Québec Longitudinal Study of Child Development.

  • Original Article |  June 19, 2013

    Prenatal Exposure to Maternal Cigarette Smoking

    Müller et al assess whether adolescents with prenatal exposure to maternal cigarette smoking differ from their nonexposed peers in the response of the ventral striatum to the anticipation or the receipt of a reward.

  • Original Article |  June 12, 2013

    Autoimmune Diseases and Mood Disorder Risk

    Benros and coauthors estimate the effect of autoimmune diseases and infections on the risk of developing mood disorders.

  • Original Article |  June 12, 2013

    Treatment-Specific Biomarker for Major Depression

    McGrath et al identify a candidate neuroimaging treatment-specific biomarker that predicts differential outcome to either medication or psychotherapy.

Multimedia >

Author Interview

Author photo

Interview with Helen S. Mayberg, MD, author of Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder

RELATED ARTICLE:

Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder

All Author Interviews >


All Author Interviews >

Author in the Room® Teleconference

Summary Points:


All Author in the Room Teleconferences >

Art and Images in Psychiatry

Leonardo da Vinci's Mona Lisa

Reader Comments

Introducing Reader Comments, a new way for readers to discuss JAMA Psychiatry articles. Select the Comments tab on article pages to read any comments and submit your own. Letters submitted to JAMA Psychiatry for consideration for print and online (archival) publication but not accepted may be accepted as Comments.

Moved to 90% Online First

With October 2012, we started our Online-First postings every Monday in each month. This means JAMA Psychiatry has moved to 90% Online-First publication and you will find something new posting every Wednesday in the month.

Firearm Violence

Articles from the JAMA Network

Introducing JAMA Network Author Video Interviews

Author Author Edwin J. van den Oord, PhD discusses A Comprehensive Family-Based Replication Study of Schizophrenia Genes.

Author Andrew H. Miller, MD discusses A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression.

Image of news@JAMA logo

Image of JAMA forum logo

Physician Jobs